Pack Su Min, Peters Peter J
The Maastricht Multimodal Molecular Imaging Institute (M4i), Faculty of Health, Medicine and Life Sciences (FHML), Maastricht University, 6229 ER Maastricht, The Netherlands.
Vaccines (Basel). 2022 Feb 3;10(2):236. doi: 10.3390/vaccines10020236.
SARS-CoV-2 vaccine production has taken us by storm. We aim to fill in the history of concepts and the work of pioneers and provide a framework of strategies employing structural vaccinology. Cryo-electron microscopy became crucial in providing three-dimensional (3D) structures and creating candidates eliciting T and B cell-mediated immunity. It also determined structural changes in the emerging mutants in order to design new constructs that can be easily, quickly and safely added to the vaccines. The full-length spike (S) protein, the S1 subunit and its receptor binding domain (RBD) of the virus are the best candidates. The vaccine development to cease this COVID-19 pandemic sets a milestone for the pan-coronavirus vaccine's designing and manufacturing. By employing structural vaccinology, we propose that the mRNA and the protein sequences of the currently approved vaccines should be modified rapidly to keep up with the more infectious new variants.
新型冠状病毒 2 型(SARS-CoV-2)疫苗的生产让我们措手不及。我们旨在梳理概念的历史以及先驱者的工作,并提供一个运用结构疫苗学的策略框架。冷冻电子显微镜在提供三维(3D)结构以及创制引发 T 细胞和 B 细胞介导免疫的候选疫苗方面变得至关重要。它还确定了新出现突变体的结构变化,以便设计能够轻松、快速且安全地添加到疫苗中的新构建体。病毒的全长刺突(S)蛋白、S1 亚基及其受体结合域(RBD)是最佳候选对象。为遏制这场 COVID-19 大流行而进行的疫苗研发为泛冠状病毒疫苗的设计和制造树立了一个里程碑。通过运用结构疫苗学,我们建议应迅速修改当前已获批疫苗的 mRNA 和蛋白质序列,以跟上传染性更强的新变种。